a subtype of the dopamine receptors, is widely dist~but~ in the nervous system and has been shown to be positively coupled to adenylate cyclase. Using a combination of in uirro receptor autoradiographic and in siiu hybridization techniques, the present study examines the co-distribution of D, receptor binding sites and D, receptor mRNA in adjacent rat brain sections. D, receptor binding sites were labeled using the selective antagonist [3H](R)-( -t )-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-IH-3-benzazepin-7-01 (SCH23390) (4.6 nM), in the presence of 1 pM ketanserin, while the D, receptor mRNA was visualized with a 35S-labeled riboprobe corresponding to a region between transmembrane domains III and VI of the rat D, receptor (base pairs 383-843). Analysis of serial sections suggested a good agreement between D, receptor binding and mRNA in several brain regions, including the paleocortex, caudate-putamen, nucleus accumbens, amygdala, and suprachiasmatic nucleus. Marked discrepancies between D, receptor binding and mRNA were observed in other brain regions including the entopeduncular and subthalamic nuclei, substantia nigra (pars reticulata), hippocampus, and cerebellum. While technical considerations may contribute to these results, much of the discordance between the distributions is probably due to the differential localization of D, receptor mRNA in cell bodies and receptor binding sites on fibers and may provide insights into receptor synthesis, transport, and membrane insertion. In the basal ganglia, for instance, D, receptors are synthesized in the striatum and are either transported to efferent projections in areas such as the substantia nigra, or remain localized in striatal cells bodies. Ibotenic acid lesions in the striatum are consistent with these conclusions and demonstrate a coordinate loss of D, receptor binding and mRNA in the caudate-putamen that is accompanied by a degeneration of fibers projecting to substantia nigra and a loss of D, binding in the pars reticulata. Neurons in the dentate gyrus and in the granular layer of the cerebellum, on the other hand, synthesize D, receptors and transport them entirely to either their dendritic or axonal fields, respectively, in the molecular layer.
Dopamine receptors in the CNS can be differentiated into two subtypes referred to as D, and D,. Because of their clinical relevance in Parkinson's disease and ~hizophre~a, a great deal of research has been generated to localize these receptor sites in the CNS 10~18,39 to examine their regulation following drug treatment and lesionssJ3~20"1 and to study the second messenger systems to which they are coupled.36 The D, dopamine receptor subtype is widely distributed in the CNS,2*4,'6 can be up-regulated by dopamine receptor antagonists, such as (1p)-( + )-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-lH-3-benzazepin-?-ol (SCH23390),7~20 and is positively coupled to adenylate cyclase via a G, protein. 6*32 D, receptors, on the other hand, are abundant in the basal ganglia and pituitary,3.9,'2 are up-regulated following 6-hydroxydo~-~To whom correspondence should be addressed, Abbreviations: EDTA, ethylenediaminetetra-acetate; 5-HT,, serotonergic sites; SCH23390, (R)-( + )-&chloro-2.3.4. 5-tetrahydro-3-methyl-5-phenyl~l~~3-benzazepin-7-ol~ SSC, sodium chloride-sodium citrate buffer: UTP. uridine triphosphate. mine lesionsi3s3' and chronic haloperidol treatment,25 and are either uncoupled or negatively coupled to adenylate cyclase. 29 The recent cloning of the D, re~ptor1',~,3',4' has provided a new means of examining issues of receptor structure, regulation, and function. The D, receptor is a 446-amino acid protein and has a 4&44% amino acid identity with other cloned catecholamine receptors including the D, receptor. Based on hydrophobicity analysis, the receptor appears to have seven transmembrane domains and contains no introns within its protein coding region. It differs from the D, receptor which contains multiple introns and a long third cytosolic loop. " Transfection of the D, clone into COS cells (COS I monkey kidney cells) produced the expression of Di specific binding (~3H]SCH23390) and a positive coupling to adenylate cyclase.
The goal of this study is to provide a qualitative examination of the D, receptor mRNA and binding site distributions in the brain using a combination of in situ hybridization and receptor autoradiographic
techniques. An obvious concern in such an analysis is that receptor binding sites and mRNA may be localized on different neuronal elements. Receptor binding is localized on both ceil bodies and fibers, while mRNA is thought to be localized primarily in cell bodies. Therefore, while regions of concordance would be expected since the Dr receptor mRNA and binding sites are products of the same gene, some anatomical discordance would not be surprising due to differential localization on neuronal fibers. Such a lack of correspondence between receptor binding and mRNA, in fact, suggests receptor transport within a neuron, something which has previously only been effectively demonstrated with lesion studies. ',38 Given the complexity of this task, this study focuses on regions of the CNS with better known circuitry, such as the hippocampus, basal ganglia, and cerebellum, with a minimal discussion of other regions of the forebrain and midbrain. To aid in determining whether the differences observed in receptor mRNA and binding are due to a differential localization on neuronal fiber, ibotenic acid legions were performed to selectively destroy cell bodies" and trace their degenerating terminals.
EXPERIMENTAL PROCEDURES

Tissue preparation and incubation medium for receptor binding studies
Adult male Sprague-Dawley rats (Charles River, 200-250g) were killed by decapitation and their brains quickly removed and frozen in liquid isopentane (-3o"C, 30s). Frozen tissues were sectioned on a Bright cryostat (20 pm), thaw-mounted on precleaned and subbed microscope slides, and stored at -80°C. Immediately prior to using the tissue, the slide-mounted sections were gradually brought to room temperature and incubated (90min, 22°C) with 200-400~1 of the selective D, antagonist [3H]SCH23390**22 (71.3 Ci/mmol) in 50 mM Tris buffer (pH 7.5 at 25°C) containing 0.1% ascorbic acid, 120 mM NaCI, 5 mM KCl, and 1 mM MgCl,. The labeling concentration of [3H]SCH23390 (4.6 nh4) was chosen to correspond to three times the K, value of the ligand2' and results in a 75% receptor occupancy. As SCH23390 has been reported to bind serotonergic sites (5-HT,), 1 PM ketanserin, a selective S-HT, antagonist, was added to all [3H]SCH23390 binding studies.
Following a 9Omin incubation period, the slides were drained, washed in four 4-min consecutive 2% ml, 50 mM Tris @H 7.6, 4°C) washes containing 0.1% ascorbic acid, 120 mM NaCl, 5 mM KCl, and 1 mM MgCl,. All slides were then quickly dipped in 250 ml distilled water (4°C) and dried with a portable hair dryer set to 'cool'. Nonspecific binding was evaluated by treating a parallel set of slides with the same concentration of t&a&d ligand with a 1 nM final concentration of unlabeled SCH23390. The slides were then apposed to tritium-sensitive Hyperfihn (Amersham) for four weeks. The Hyperfllm was exposed at room temperature, developed in Kodak D-19 (4min, 19C), agitated in 2% acetic acid (30 s), fixed in Kodak Rapidfix (5 min), and washed under running water (30min). Anatomical structures were determined using Nissl-stained sections in conjunction with the atlas of Paxinos and Watson3'
In situ hybridization Slides adjacent to those used for autoradiographic mapping of D, binding sites were directly removed from storage at -80°C and placed into 4% formaldehyde for 60 min (22°C) prior to being processed for in situ hybridization.a'5," Following three 5-min rinses in phosphatebuffered saline (PH 7.4), sections were treated with proteinase K (1 rg/ml in 1OOmM Tris, pH 8.0, 50mM EDTA) for 10 min at 37°C. Slides were then rinsed in water, followed by 0.1 M triethanolamine @H 8.0), and treated with a mixture of 0.1 M triethanolamine (pH 8.0) and acetic anhydride (4OO:l vol:vol) with stirring for 10min. The sections were then rinsed in 2 x sodium chloride-sodium citrate butfer (SSC) (300 mM NaCl, 30 mM sodium citrate, pH 7.2) for 5 min, dehydrated through graded alcohols, and allowed to air dry.
Brain sections were hybridized with a [?S]uridine triphosphate (UTP)-labeled 480-bp riboprobe generated to the region of the rat D, receptor spanning transmembranes III-VI (base pairs 383-843). cRNA probes generated with a pGEM transcriptional vector were diluted in hybridization buffer (75% formamide, 10% dextran sulfate, 3 x SSC, 50 mM Na,PO,, pH 7.4, 1 x Denhardt's, 0.1 mg/ml yeast tRNA, 0.1 mgjml sonicated, denatured salmon sperm DNA, 10 mM dithiothreitol) to result in a final concentration of 2 x lO"d.p.m./30~1. Volumes of 30 and 50~1 of diluted probe were applied to coronal and horizontal sections, respectively.
After hybridization (overnight, 55°C) the slides were rinsed in 2 x SSC (5 min) and treated with RNase A (200 ,ug/ml in 1OmM Tris, pH 8.0, and 0.5 M NaCl) for 60min at 37°C. Subsequently, sections were rinsed in 2 x SSC for 10min (22"C), 1 x SSC for 10min (22"C), 0.5 x SSC at 55°C for 60 min, 0.5 x SSC at room temperature for lOmin, and finally dehydrated in graded alcohols and air-dried. Sections were then either exposed to Kodak XAR-5 X-ray tllm for three to 10 days and developed, or dipped in Kodak NTB-2 emulsion and stored at 4°C prior to development 14 days later.
Ibotenic acid lesions
Ten male Sprague-Dawley rats (200-250g) were anesthetized and placed in a Kopf stereotaxic apparatus. To ensure that the right rostral caudateputamen was completely ablated, ibotenic acid (2.0 pg/pl) dissolved in phosphate-buffered saline was infused at three different coordinates in the caudate-putamen using a 30-gauge cannula. With skull flat, the coordinates were B + 2.0/2.5/5.5, B + 1.0/3.0/5.5 and B -0.4/4.0/5.5 corresponding in rnillimeters to the anterior-posterior/lateral/and ventral planes as illustrated in the Paxinos and Watson atlas." An infusion of 1 p 1 was given over a time interval of 2 min at each site and the cannula was allowed to remain in place for 5 min prior to removal. Fourteen days following the lesion, animals were killed by decapitation and their brains were frozen as described above. Brains were sectioned and processed for in situ hybridization and receptor autoradiography as described above. The extent of neuronal cell loss was evaluated with Nissl-stained sections and reference to the atlas of Paxinos and Watson.33 "Sense"-strand control
To assess whether the in situ signal reflected specific hybridization to the D, receptor mRNA, a "sense"-strand control study was performed whereby a series of paired, adjacent sections was divided into two sets. One set of slides was treated according to the in situ protocol described above, while the second set was treated identically, except that the cRNA probe used in the hybridization mixture was [3sS]UTP-labeled sense-strand RNA. Within the telencephalon, the highest levels of D, receptor binding and mRNA are observed in the basal ganglia. In the ~udat~putamen (Fig. IA, D) , D, receptor binding is densest in the head of the caudate-putamen with a rostral-to-caudal gradient observed. In addition, there are medial-lateral differences, with the densest binding found in the dorsomedial and ventrolateral portions of this nucleus. D, receptor mRNA (Fig. lB, E ) appears more uniform in the caudate-putamen, with somewhat higher levels observed ventrolaterally. Ventrally in the nucleus accumbens, dense levels of D, receptor binding and mRNA are observed particularly in the shell and extend into the core (Fig. lD, E) . Both D, receptor binding and mRNA show rostra]-to-~udal gradient in the nucleus accumbens, with the highest level of D, receptors observed rostrally. The olfactory tubercle similarly demonstrates high levels of D, receptors, with the D, receptor mRNA levels (Fig. lB, C) exceeding those observed in the caudate+putamen and nucleus aceumhens.
A region of discordance between D, receptor mRNA and Dt receptor binding is the globus and ventral pallidum ( Fig. 2A, B) . In the globus pallidus, a region with major projections from the striatum, there are low levels of D, receptor binding with moderate levels observed in the ventral pallidurn. In contrast, only a few cells of either the globus or ventral pallidum show D, receptor mRNA. Similarly, in the septum, moderate levels of D, receptor binding are observed in the lateral nucleus with dense binding along its outer boundary, yet little D, receptor mRNA can be detected. The medial nucleus of the septum also shows a low level of D, receptor binding and no D, receptor mRNA, suggesting an absence of receptor synthesis in this region.
Within the hippocampal formation and dentate gyrus, D, receptor binding is moderate to low, with binding observed in the molecular layer of the dentate gyrus and in the stratum moleculare of the hippocampal formation (Fig. 2C) . Interestingly, D, receptor mRNA is localized in the granular cell layer of the dentate gyrus and no D, receptor mRNA could be detected in the ~p~~~ formation (Fig. 2D ). This suggests both a transport of D, receptors within dentate gyrus and an extra-hippocampal projection to the striatum moleculare of the hippocampus.
The amygdaloid complex, a region with varying densities of D, receptor binding, shows a good correspondence between D, receptor binding mRNA (Fig. 3A, B) . The basolateral, lateral and central nuclei show low levels of D, receptor mRNA and a moderate amount of D, binding (Fig. 3) . Similarly, moderate-to-dense levels of D, binding and mRNA appear co-localized in the cortical and basomedial amyg~loid nuclei (Fig. 3A, B) .
Diencephulon
The vast majority of the nuclei of the diencephalon show only low levels of D, receptor binding. Within the hypothalamus, low levels of D, binding are observed in most nuclei (Fig. 2C ) with somewhat higher levels in the arcuate nucleus. Only the suprachiasmatic nucleus of the hypothalamus shows moderate-to-dense D, binding ( Fig. 2A) . Similarly, D, receptor mRNA is undetectable in most of the hypothalamic nuclei with low-to-moderate levels observed only in the suprachiasmatic nucleus (Fig. 2B ).
More dorsally, the thalamus shows only low levels of DI receptor binding in most nuclei with the habenula demonstrating moderate levels. D, receptor mRNA is undetectable in most of the thalamus.
The entopeduncular nucleus, a region receiving projections from the striatum, shows dense levels of D, receptor binding and no D, mRNA (Fig. 4A, B) . Such a marked discordance between D, receptor binding and mRNA suggests that the dopaminergic binding observed in this nucleus is localized on striatal projections. There is dense D, receptor labeling in the caudateputamen that extends to the ento~uncular nucleus and substantia nigra, as can be seen from Fig. 4A . In fact, the D,-containing fibers appear to course through the internal capsule and terminate in the substantia nigra. By comparison, D, receptor mRNA (Fig. 43) is observed only in the cat&ate-putamen which probably contains the cells of origin.
Similarly, in the subthalamic nucleus, a region receiving projections from the globus pallidus, also demonstrates dense D, receptor binding and no D, mRNAI su~esting that the binding sites are localized on fibers.
Mesencephalon
In the midbrain, low levels of D, receptor binding are observed in the interpeduncular nucleus, periaqueductal gray, raphe nuclei, inferior colliculus, and medial geniculate, with the superior colliculus demonstrating a moderate density of receptor binding (Fig. 5A) . Within the dopaminergic cell groups, low levels of D, receptor binding can be observed in the ventral tegmental area and the pars compacta of the substantia nigra, while dense D, binding is found in the pars reticutata of the substantia nigra (Figs 4A, SA) . Despite the presence of D, receptor binding, no D, receptor mRNA could be detected in the substantia nigra, ventral tegmenti area, superior and inferior colliculi, periaqueductal gray, raphe, or medial geniculate nucleus (Figs 4B, 33) . A. MANSOUR ef al. 
Cerebellum
predominantly in the molecular layer of the cerebelBecause of its precise lamination, the cerebellum, lum (Fig. 5C) , where low-to-moderate levels are like the hippocampus, is an excellent tissue for examobserved. This layer of the cerebellum receives intrinining receptor localization. D, receptor binding is sic projections from the granular cell layer where (Fig. 5D) .
"Sense"-strand controls
No specific hybridization was observed with sections labeled with the sense-strand probe, while the antisense riboprobe showed specific hybridization (data not shown).
Ibotenic acid lesions
The ibotenic acid lesions were restricted to the candate-putamen and primarily damaged the head and the rostra1 portion of the body of the caudate-putamen. Areas of cellular death, as determined by Nissl staining, corresponded precisely to regions of D, receptor binding and mRNA loss (Fig. 6A, B) . ( Fig. 6C) suggesting that the D, receptors found in this region are localized on fibers originating in the caudate-putamen.
DISCUSSION
A good correspondence between D, receptor binding and mRNA was found in areas such as the paleocortex, caudate-putamen, nucleus accumbens, olfactory tubercle, endopi~fo~ nucleus, suprachiasmatic nucleus, and amygdala. In addition, there appears to be a correlation in the relative abundance of D, receptor binding and mRNA, such that regions of high receptor binding generally demonstrate high levels of D, receptor mRNA, while areas of low receptor binding demonstrate little or no D, receptor mRNA. The amygdaloid complex is a particularly good example of such a correspondence, with specific nuclei displaying varying levels of DI receptor binding which correlated precisely to the relative amounts of Dr receptor mRNA found in these areas.
of correspondence. While a consideration, it is an unlikely factor, as r3H'JSCH23390 has been reported to be a highly selective D, antagonistgJ2 and any 5-HT, receptor effects it may have should have been blocked with the addition of 1 pM ketanserin used in the present study. With regard to the selectivity of the riboprobe, the D, receptor is approximately 40% homologous to the D, receptor and studies from our laboratory have, in fact, demonstrated that the D, and DZ receptor mRNA ~stributions can be easily differentiate in the CNS using this riboprobe and these hydridization conditions (unpublished observations). However, we cannot rule out the possibility that this riboprobe may hybridize to a yet uncloned receptor or a variant of the D, receptor.
Similarly, within the dopaminergic terminal fields of the basal ganglia, high levels of both D, receptor mRNA and binding are observed. In the nucleus accumbens, dense levels of D, receptor binding are seen in the shell and extend to form islands of very dense binding in the core of the nucleus. A gradient of D, binding is also seen with binding levels higher in the more rostral extent of the nucleus accumbens. D, receptor mRNA is similarly localized in the accumbens with higher levels observed in the rostra1 extent, and patches of very dense receptor mRNA are observed, In the caudate-putamen, no obvious rostral-to-caudal gradient in mRNA levels could be detected, while a rostra&o-car&al gradient in receptor binding was seen in this and in other studies.3*'o~23 The D, receptor mRNA distribution within the caudate-putamen is not homogeneous, however, with higher levels observed in the dorsomedial and ventrolateral portions of the nucleus, regions that correspondingly have higher amounts of D, receptor binding. The olfactory tubercle, a third major dopaminergic terminal field, has both high levels of Dr binding and mRNA.
A second factor that may contribute to a lack of correspondent is that of sensitivity. This may be an issue in areas with a low density of D, receptors, such as most of the nuclei in the hypothalamus and thalamus, inferior colliculus, medial septum, interpeduncular nucleus, periaquaductal gray, raphe, and ventral tegmental area. These regions contain low levels of D, receptor binding and no detectable mRNA, suggesting a possible lack of sensitivity with present in situ hybridization techniques.
A third technical factor that may influence these results is that of differential quenching of the isotopes used to label the binding sites and mRNA. Clearly, [3H]SCH233~0 is differentially quenched in the brain, influencing the grain densities observed in various regions. As 35S-labeled riboprobes are stronger beta emitters, differential quenching is less of a problem, but still can contribute to the results. An iodinated ligand could have been used to label the D, binding sites; however, differential quenching between "S and lz51 would still need to be considered. , and the molecular layers of the dentate gyms, ~p~ampus and cerebellum, yet no D, receptor mRNA can be detected. Such regions of marked discrepancy between D, receptor binding and mRNA are likely due to a differential localization of mRNA in cell bodies, and binding sites on fibers and strongly suggest the presence of a specific transport of dopamine@ receptors not entirely appreciated using receptor autora~o~ap~c techniques alone. Among the technical considerations that may conBased on lesion studies of the nigrostriatal system tribute to this discrepancy in receptor binding and and receptor autoradiographic results,2*4~'4*'9~"V3* sevmRNA is ligand and probe. selectivity. More specifi-eral investigators have suggested that D, receptorcally, the ligand or riboprobes chosen may label containing cells are localized predominantly in the receptors other than D, thereby contributing to a lack striatum and project caudally via the internal capsule and terminate in the globus pallidus, entopeduncular nucleus and the pars reticulata of the substantia nigra. Our in situ results are consistent with such a scheme and demonstrate D, receptor mRNA only in the striatum and not in any of these projection targets. Our ibotenic acid lesion results are also consistent with previous report~**~ and demonstrate a coordinate loss of D, receptor mRNA and binding in the cells of the striatum and a degeneration of fibers and loss of D, receptor binding in the substantia nigra.
Comparison of D, receptor binding and mRNA in the nigrostrlatal system suggests that striatal neurons can synthesize D, receptors which are either transported along their fiber projections, or remain localized within the cell soma itself. This is probably not the case in other brain regions, such as the dentate gyrus and cerebellum. Neurons in these brain areas likely synthesize the D, receptor in their cell bodies and transport them mainly to either their dendritic (dentate gyrus) or axonal (cerebellum) fields as evidenced by the differential localization of D, receptor mRNA in the granular cell layers and D, binding in the molecular layers of both the dentate gyrus and cerebellum.
transported to sites distant from the point of transcription, such as the lateral system or hypothalamus where D2 binding can be measured. D,containing neurons of the substantia nigra pars compacta demonstrate yet another example, with the synthesis and transport the D, receptor to both their soma in the substantia nigra and their fibers in the forebrain. It is evident from both the D, and D2 receptor results that different populations of neurons are capable of directing the transport and ultimate insertion of receptors to specific regions of their neuronal membranes affecting neuronal excitability and specificity.
Within the hippocampal formation, D1 receptor binding is found predominantly in the molecular layer, but no D, mRNA is detected in the pyramidal cell layer, suggesting an extra-hippocampal source, such as cells in the entorhinal cortex that are known to terminate in the molecular layer of the hippocampus.
Though by no means complete, this analysis provides a better understanding of the dopamine receptor anatomy in terms of both its circuitry and cellular elements. While the use of receptor autoradiography has been invaluable in understanding the distribution of receptor binding sites, it cannot easily distinguish which binding sites are localized on cell bodies or fibers. Its combination with in situ hybridization techniques provides a new means of visualizing potential circuits and the differential cellular transport of receptors. The sensitivity of such an analysis largely depends on the anatomical substrate involved, with regions of discrete receptor binding, such as the suprachiasmatic nucleus, or laminated brain areas, such as the cerebellum, hippocampus and olfactory bulb being more amenable for this analysis. Similarly, well-defined circuits, such as the nigrostriatal system, are far easier to examine relative to other brain areas.
In addition to long striatonigral projections, D, receptors are apparently localized within local circuits. The co-localization of D, receptor mRNA and binding in discrete nuclei of the amygdala and the suprachiasmatic nucleus, for example, suggest that D, binding sites in these areas are either found on cell bodies or are on short or intrinsic projections. It is conceivable, however, that despite such a co-distribution, the D, receptor mRNA and binding may not be localized in the same cells with, for example, the D, binding on terminals of one population of cells and mRNA on another within the same nuclei. While it is difficult at present to determine the exact nature for such a co-localization, the use of electron microscopy and immunohistochemistry should be able to differentiate these possibilities.
What remains unclear, however, is which sites are functional. Receptor sites in long axonal projections may not be coupled to second messenger systems and unable to mediate physiological responses. While nascent receptors may be able to bind a ligand, they may not be functional until they have been inserted into terminals or dendritic membranes. Clearly, the present results need to be combined with microinjection studies to gain a better understanding of the anatomical circuitry and physiology. Future studies combining these techniques with other anatomical methods of visualizing second messengers or phosphoinositide tumove?
will also be important in resolving these biological issues.
Comparison of D2 receptor mRNA and binding similarly suggests that the D2 receptor is also differentially transported within neurons of the CNS.*' In the zona incerta, for example, high levels of D2 receptor mRNA can be observed with little or no D, binding, suggesting that the D, receptor is translated and
